Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 659

1.
2.

PDGF receptor beta is a potent regulator of mesenchymal stromal cell function.

Tokunaga A, Oya T, Ishii Y, Motomura H, Nakamura C, Ishizawa S, Fujimori T, Nabeshima Y, Umezawa A, Kanamori M, Kimura T, Sasahara M.

J Bone Miner Res. 2008 Sep;23(9):1519-28. doi: 10.1359/jbmr.080409.

3.

Spontaneous In Vivo Chondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling.

Marsano A, Medeiros da Cunha CM, Ghanaati S, Gueven S, Centola M, Tsaryk R, Barbeck M, Stuedle C, Barbero A, Helmrich U, Schaeren S, Kirkpatrick JC, Banfi A, Martin I.

Stem Cells Transl Med. 2016 Dec;5(12):1730-1738. Epub 2016 Jul 26.

4.

Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.

Li CY, Wu XY, Tong JB, Yang XX, Zhao JL, Zheng QF, Zhao GB, Ma ZJ.

Stem Cell Res Ther. 2015 Apr 13;6:55. doi: 10.1186/s13287-015-0066-5.

5.

Differentiation-dependent up-regulation of BMP-2, TGF-beta1, and VEGF expression by FGF-2 in human bone marrow stromal cells.

Farhadi J, Jaquiery C, Barbero A, Jakob M, Schaeren S, Pierer G, Heberer M, Martin I.

Plast Reconstr Surg. 2005 Oct;116(5):1379-86.

PMID:
16217482
6.

The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro.

Shen B, Wei A, Whittaker S, Williams LA, Tao H, Ma DD, Diwan AD.

J Cell Biochem. 2010 Feb 1;109(2):406-16. doi: 10.1002/jcb.22412.

PMID:
19950204
7.

A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells.

Nedeau AE, Bauer RJ, Gallagher K, Chen H, Liu ZJ, Velazquez OC.

Exp Cell Res. 2008 Jul 1;314(11-12):2176-86. doi: 10.1016/j.yexcr.2008.04.007. Epub 2008 Apr 25.

8.

Choice of xenogenic-free expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells.

Brun J, Abruzzese T, Rolauffs B, Aicher WK, Hart ML.

Cytotherapy. 2016 Mar;18(3):344-59. doi: 10.1016/j.jcyt.2015.11.019.

PMID:
26857228
9.

Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells.

Hoch AI, Binder BY, Genetos DC, Leach JK.

PLoS One. 2012;7(4):e35579. doi: 10.1371/journal.pone.0035579. Epub 2012 Apr 20.

10.

Impact of bladder-derived acellular matrix, growth factors, and extracellular matrix constituents on the survival and multipotency of marrow-derived mesenchymal stem cells.

Antoon R, Yeger H, Loai Y, Islam S, Farhat WA.

J Biomed Mater Res A. 2012 Jan;100(1):72-83. doi: 10.1002/jbm.a.33230. Epub 2011 Oct 4.

PMID:
21972045
11.

Bone marrow mesenchymal stem cells overexpressing human basic fibroblast growth factor increase vasculogenesis in ischemic rats.

Zhang JC, Zheng GF, Wu L, Ou Yang LY, Li WX.

Braz J Med Biol Res. 2014 Oct;47(10):886-94. Epub 2014 Aug 8.

12.

Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats.

Liu N, Zhang Y, Fan L, Yuan M, Du H, Cheng R, Liu D, Lin F.

J Transl Med. 2011 Jul 6;9:105. doi: 10.1186/1479-5876-9-105.

13.

Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells.

Xiao L, Sobue T, Esliger A, Kronenberg MS, Coffin JD, Doetschman T, Hurley MM.

Bone. 2010 Aug;47(2):360-70. doi: 10.1016/j.bone.2010.05.021. Epub 2010 May 25.

14.

Age-dependent decrease in the chondrogenic potential of human bone marrow mesenchymal stromal cells expanded with fibroblast growth factor-2.

Kanawa M, Igarashi A, Ronald VS, Higashi Y, Kurihara H, Sugiyama M, Saskianti T, Pan H, Kato Y.

Cytotherapy. 2013 Sep;15(9):1062-72. doi: 10.1016/j.jcyt.2013.03.015. Epub 2013 Jun 22.

PMID:
23800732
15.

Canine Mesenchymal Stem Cell Potential and the Importance of Dog Breed: Implication for Cell-Based Therapies.

Bertolo A, Steffen F, Malonzo-Marty C, Stoyanov J.

Cell Transplant. 2015;24(10):1969-80. doi: 10.3727/096368914X685294. Epub 2014 Nov 5.

PMID:
25375819
16.

Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.

Zhao L, Li G, Chan KM, Wang Y, Tang PF.

Calcif Tissue Int. 2009 Jan;84(1):56-64. doi: 10.1007/s00223-008-9189-3. Epub 2008 Dec 4.

PMID:
19052794
17.

Isolation and multilineage differentiation of bone marrow mesenchymal stem cells from abattoir-derived bovine fetuses.

Cortes Y, Ojeda M, Araya D, Dueñas F, Fernández MS, Peralta OA.

BMC Vet Res. 2013 Jul 5;9:133. doi: 10.1186/1746-6148-9-133.

18.

Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem Cells.

Kalomoiris S, Cicchetto AC, Lakatos K, Nolta JA, Fierro FA.

J Cell Biochem. 2016 Sep;117(9):2128-37. doi: 10.1002/jcb.25519. Epub 2016 Mar 8.

19.

Supplemental Content

Support Center